Tuesday's small-cap news flow was dominated by half-year results season, with a clear theme emerging across sectors: companies trading growth for margin discipline. Vulcan Two Group led the way by deliberately cutting unprofitable customers even as it integrates three acquisitions, while Synthomer and Strix both delivered upgraded outlooks built on cost control rather than top-line surges.
Vulcan Two prunes weak clients as pharmacy roll-up beds in
Vulcan Two Group (LSE:VUL), which is building a regulated UK ePharmacy platform through acquisition, reported strong sales growth in general healthcare, particularly women's health and ADHD medications, in the six months to 30 June. Having acquired CloudRx, Hyperdrug and Webmed on 19 March, the group has since cut a small number of lower-margin, higher credit-risk customers, mostly weight-loss clinics, a move it expects will dent near-term revenue but lift gross margin percentage. The shares fell 13.73% to 220.0p as the market digested the near-term revenue trade-off.
Point-of-order payments now account for 85% of revenues, supporting cash conversion and limiting bad-debt exposure, with cash balances of approximately £6.0m at period end. Higher 2026 operating costs stemming from early hires and double-running expenses are expected to fall away in 2027. Integration progress includes fit-out of a 22,000 sq ft Leeds distribution facility on track for year-end completion, ERP system integration, and the transfer of Webmed's fulfilment into CloudRx. Keith Butcher has joined as chief financial officer, and a naming agency has been appointed to unify the group's brand, with an announcement expected within weeks.
"We operate in a large, fragmented and fast-growing market with strong structural tailwinds," said Michael Kraftman, Chief Executive.
The decision to sacrifice revenue for margin quality this early in a roll-up strategy signals a management team unwilling to chase growth for its own sake, a notable discipline given how many acquisitive small-caps prioritise scale over unit economics. With cash-conversion metrics already improving and integration milestones tracking on schedule, the near-term share price reaction looks more like a repricing of growth expectations than a red flag on execution.
Strix reports "positive momentum" as cash boosted by Billi sale
Strix Group (AIM:KETL), the maker of kettle safety controls and water filtration products, posted group revenue of £153.2m at constant exchange rates for the 15-month period ended 31 March, up 6.2% and flattered by the longer reporting period after the company shifted its year end. Adjusted profit before tax came in at £10.1m at constant exchange rates, which the company said was firmly within its forecast range, and shares edged up 0.58% to 34.5p.
The disposal of Billi, sold to Crescent Capital Partners at an enterprise value of £110m, generated net cash proceeds of £102m, around three times Strix's original £38m investment when it acquired the business in November 2022. That transaction moved Strix to a net cash position of £38.7m, funding £13.7m of capital returned to shareholders so far through a tender offer and share buyback. For the 12 months to March 2026, Controls revenue fell 23.8% at constant exchange rates to £52.9m, which the company attributed to a challenging macro environment.
"Strix has entered FY27 with positive momentum," Gary Lamb, Chief Executive, while the chairman, added the board "remains confident in Strix's ability to deliver sustainable long-term growth." The Billi exit at a substantial multiple to cost transforms the balance sheet from a leveraged position into a cash-generative one, giving management room to fund shareholder returns while it works through the core Controls business's cyclical decline.
Gulf Marine Services converts bridge loan and expands credit lines
Gulf Marine Services (LSE:GMS), a provider of self-propelled, self-elevating support vessels to the offshore energy industry, has converted its January 2026 bridge loan, the AED-equivalent of $37.4m, drawn to fund a vessel acquisition, into a five-year term loan. The company says the move does not increase its overall indebtedness but shifts short-term acquisition financing onto a structure matching the vessel's long-term ownership. Shares ticked up 0.32% to 18.88p.
The conversion sits within GMS's existing syndicated lending arrangement, with HSBC, First Abu Dhabi Bank and Commercial Bank of Dubai retaining the same margin, covenant package and security terms as before; no new lenders have joined and pricing is unchanged. Separately, GMS secured an additional AED-equivalent $7.5m working capital facility from Commercial Bank of Dubai to support expansion into new geographies, with up to 40% drawable in cash.
"The successful conversion of this facility onto a long-term basis reflects the continued support of our banking syndicate and provides the Company with cost-effective financing appropriate to the useful life of the Vessel," said Alex Aclimandos. The refinancing tidies up the maturity profile without adding leverage, a modest but useful step for a business whose vessel-heavy balance sheet depends on lenders matching debt duration to asset life.
CT Automotive revenue climbs but H1 profit hit by cost pressures
CT Automotive Group (LSE:CTA), a designer and supplier of interior components to the global automotive industry, reported revenue up 15% to $62.1m in the six months to 30 June, against $54.1m a year earlier. Production revenue rose 14% to $56.9m and tooling revenue climbed 30% to $5.2m, growth the company described as slightly ahead of expectations and driven by strong customer demand and new programme launches at its Mexico facility. Shares slumped 24.25% to 40.15p.
Underlying pre-tax profit for the first half is expected to fall materially below the prior-year comparative, after geopolitical instability pushed up operating costs and disrupted supply chains, prompting higher freight costs and increased stockholding in Mexico, alongside unplanned costs from rectifying production inefficiencies during the ramp-up. Facilities in China and Türkiye continue to perform in line with expectations, with cost efficiencies already visible in Türkiye and further gains expected as China consolidates into a single site.
"Our factory operating system is the clearest example of how we are changing the way this business runs," said Simon Phillips, Chief Executive. The scale of the share price reaction reflects investor concern that Mexico ramp-up costs may prove stickier than management suggests, even as the underlying revenue growth story remains intact.
Symphony Environmental says early trading is validating its model
Symphony Environmental Technologies (AIM:SYM) told shareholders it returned to profit in the first half, helped by margin gains and tighter cost control. Shares climbed 9.09% to 9.0p on the update.
The plastics additives specialist's return to profitability, delivered through cost discipline rather than a step-change in revenue, suggests management is finally converting years of technology investment into a sustainable earnings base.
Synthomer upgrades full-year outlook on strong first-half margins
Synthomer (LSE:SYNT) lifted its 2026 profit and cash guidance after first-half EBITDA rose 16.4% and net debt came in better than expected. The speciality chemicals group's shares jumped 16.11% to 103.34p.
The upgrade points to a business that has successfully restructured its cost base after a torrid few years for chemicals demand, and the improved net debt position gives management more room to invest without pressuring the balance sheet.
Xaar swings to profit as printhead demand lifts H1 revenue
Xaar (AIM:XAR) reported a first-half return to profitability on 9.2% constant-currency revenue growth, with strong pre-launch demand for the Flashforge CJ270 printer validating its push into new applications. Shares slipped 0.91% to 119.4p despite the improved numbers.
The pre-launch traction for the Flashforge CJ270 is the more telling detail here, suggesting Xaar's diversification beyond its traditional printhead base is gaining genuine commercial pull rather than remaining a pipeline story.
Focusrite reiterates full-year outlook as demand stays healthy
Focusrite (AIM:TUNE) told shareholders trading remains in line with expectations, with early sales running ahead of last year. Shares rose 1.27% to 240.0p.
The steady reiteration, rather than an upgrade, suggests the audio equipment group is consolidating gains from prior periods rather than accelerating, a reassuring if unspectacular signal for holders.
Metir signs UK water alliance as SRB kit production nears restart
Metir (AIM:MET) struck a UK distribution tie-up with MechLine-UK and confirmed QuickChek SRB kit production will resume in October after a supply halt. Shares rose 5.2% to 0.789p.
Resolving the supply disruption while simultaneously securing a new distribution channel gives the environmental monitoring group a clearer route back to sales momentum heading into the final quarter.
CLS Holdings cuts full-year EPS guidance
CLS Holdings cut its full-year earnings-per-share guidance, citing pressure on near-term earnings even as it continues to execute against strategic priorities.
"While near-term earnings are under pressure, we continue to make progress against our strategic priorities," the company said, a framing that points to a business prioritising portfolio repositioning over short-term earnings optics.
XP Power reveals order growth
XP Power (LSE:XPP) posted a 55% surge in order intake in its first half, backing unchanged full-year guidance as £135m of firm orders point to a stronger second half. Shares fell 3.58% to 1670.0p despite the order momentum.
The disconnect between strong order growth and a falling share price suggests investors are focused on the timing of conversion into revenue rather than doubting the underlying demand signal.
Winvia Entertainment lifts H1 EBITDA on prize draw and gaming growth
Winvia Entertainment (AIM:WVIA) reported higher first-half EBITDA driven by growth across its prize draw and gaming operations. Shares rose 0.55% to 254.9p.
"We are well positioned to maintain this momentum through the second half and remain firmly on track to deliver full year expectations," said chief executive Mihai Manoila, reinforcing confidence that recent growth is structural rather than seasonal.
Bradda Head strikes solar land deal in Pennsylvania
Bradda Head Lithium (AIM:BHL) agreed a solar land deal in Pennsylvania that allows a third-party developer to progress a solar project on its site while the company retains its brine lease, mineral rights and access for future development. Shares fell 5.96% to 2.116p.
"This agreement enables the proposed solar development to progress while preserving the company's brine lease, mineral rights and access for potential future development," said Ian Stalker, a structure that lets Bradda Head monetise otherwise idle land without compromising its core lithium ambitions.
Likewise Group doubles retail offer to £4m on strong demand
Likewise Group (AIM:LIKE) has upsized its retail share offer after applications significantly exceeded the original £2m target. Shares fell 3.95% to 29.775p.
The oversubscription for the AIM-listed flooring distributor's retail offer points to healthy investor appetite for the stock even as the shares themselves traded lower on the day.
Sound Energy completes $57m Meridja sale to Managem
Sound Energy (AIM:SOU) completed the $57m sale of its Meridja asset to Managem, giving the company a strengthened cash position to pursue new opportunities. Shares rose 3.92% to 1.6628p.
"We have capital to invest, a clear investment strategy and are already evaluating opportunities that can build a larger, diversified and cash-generative energy business," said chief executive Majid Shafiq, signalling the disposal proceeds will fund the next phase of portfolio expansion rather than sit idle.
KEFI says Tulu Kapi schedule sees "full production" in 2028
Kefi Gold And Copper (AIM:KEFI) said its flagship Ethiopian gold project remains on track for commissioning in late 2027, with resettlement compensation now fully agreed and equipment procurement past the halfway mark. Shares rose 5.53% to 1.125p.
Clearing the resettlement compensation overhang removes one of the project's longstanding execution risks, leaving equipment procurement progress as the next milestone investors will watch ahead of the 2027 commissioning target.
SIG suspends dividend as first-half loss widens amid weak construction demand
Sig (LSE:SHI) suspended its dividend as first-half losses widened amid persistently weak construction demand. Shares rose 2.27% to 9.0p despite the suspension.
Chief executive Pim Vervaat said markets are not expected to recover through the remainder of 2026 and "possibly throughout 2027," a bluntly cautious outlook that suggests management is prioritising balance sheet preservation over near-term shareholder returns.
Filtronic "excited about opportunities", investments dampen earnings
Filtronic (AIM:FTC) saw near-term earnings dampened by investment spend even as it pointed to a strong order book underpinning FY2027 revenues. Shares fell 9.16% to 228.0p.
"With a strong order book already providing substantial coverage for FY2027 revenues and growing engagement across key programmes, we are excited about the opportunities ahead," said chief executive Nat Edington, though the share price move suggests investors are weighing near-term margin dilution against that longer-term revenue visibility.
ITM Power hits milestone as Lingen hydrogen reaches customer
ITM Power (AIM:ITM) reached a milestone as its Lingen hydrogen production facility delivered its first output to a customer. Shares rose 4.32% to 106.2p.
"This is a landmark achievement for the hydrogen industry and a proud moment for ITM Power," said chief executive Dennis Schulz, marking a tangible commercial proof point after years of pre-revenue development in the green hydrogen sector.
FIH group agrees sale of Momart to French buyer
FIH group (AIM:FIH) agreed the sale of its Momart fine art logistics business to a French buyer. Shares surged 20.93% to 130.0p on the disposal news.
Chief executive Stuart Munro described it as a positive transaction for the group, with the market's sharp reaction suggesting the sale terms were more favourable than investors had anticipated.
MedPal AI hits £8.6m revenue run rate after record July
MedPal AI (AIM:MPAL)'s annualised revenue run rate has risen more than 70% in two months, with all three revenue streams now recording their best month yet. Shares jumped 19.35% to 3.7p.
The breadth of the acceleration, across all three revenue lines simultaneously, points to genuine platform traction for the AI-native pharmacy and digital health group, rather than a single product driving the improvement.
Genedrive test adopted at leading Dutch hospital
genedrive (AIM:GDR) saw Erasmus MC become the first Netherlands medical centre to roll out its rapid newborn hearing-loss test. Shares rose 12.5% to 1.125p.
Adoption by a leading academic medical centre gives genedrive a credible reference site as it looks to expand the test's footprint across European hospital networks.
Phoenix Copper clears Indigo Capital loan in full
Phoenix Copper (AIM:PXC) has repaid the full principal owed to Indigo Capital, closing out the convertible loan agreement struck in December. Shares rose 5.05% to 0.4097p.
Clearing the convertible loan removes a source of potential dilution overhang, a modest but welcome balance sheet clean-up for the small-cap.
Great Western sets drilling start at Defender tungsten project
Great Western Mining Corporation (AIM:GWMO) has appointed Addison Mining Services as Competent Person ahead of drilling starting within two weeks at its Defender Tungsten Project in Nevada. Shares rose 8.56% to 3.4195p.
The imminent drilling start marks a concrete step forward for the tungsten project after a period of preparatory work, giving investors a near-term catalyst to watch for.
Eden Research wins Mevalone approvals in Slovakia and Egypt
Eden Research (AIM:EDEN) secured Mevalone approvals in both Slovakia and Egypt, expanding its biopesticide's regulatory footprint. Shares rose 3.14% to 2.63p.
"Egypt marks the first authorisation in North Africa for Mevalone and with no pre-harvest interval on the label, it provides a strong advantage for growers supplying highly regulated export markets," said chief executive Sean Smith, highlighting a genuine commercial edge over competing products in export-focused agriculture.
